Antidepressant effects exerted by PDE4 inhibitors through the enhancement of cAMP signalling are mainly attributable to the inhibition of PDE4D.38 It is conceivable that our finding of PDE4DIP upregulation in MDD individuals indicates increased compartmentalization of PDE4D leading to altered cAMP availability. The gene discussed is PDE4A; the disease is major depressive disorder.